Mutation-targeted Bladder Cancer Drug Found Under-used : vim

Bladder cancer drug targeting a cancer-driving gene mutation has been used relatively little despite its clear efficacy in a clinical trial.

Related Keywords

, Bladder Cancer , Under Used , Utation , Clinical Trial , Erdafitinib , Urothelial Carcinomas ,